Purdue Pharma Could Pay Billions For Role In Opioid Epidemic

The owners of Purdue Pharma could pay up to $6 billion for its role in the opioid epidemic.

Under the settlement, the company is not protected from future liabilities.

The agreement would still needs approval from a federal bankruptcy judge.

If approved, it will secure more than $1 billion which would be more money than the previous deal.